首页 | 本学科首页   官方微博 | 高级检索  
检索        


Updates in the Evaluation and Management of Breast Cancer
Authors:Ciara C O&#x;Sullivan  Charles L Loprinzi  Tufia C Haddad
Institution:Division of Medical Oncology, Mayo Clinic, Rochester, MN
Abstract:Breast cancer is the most commonly diagnosed cancer worldwide. More than 200,000 new cases of invasive breast cancer are diagnosed annually in the United States; approximately 40,000 patients die of the disease. The etiology of most breast cancer cases is unknown, although multiple factors predisposing to the disease have been identified. Apart from increasing age and female sex, these other factors account for only a minority of breast cancer diagnoses. This article provides an overview of the management of noninvasive and invasive breast cancer, which is often complex and varies according to patient factors, disease stage, and breast cancer subtype. Although much progress has been made, continued research endeavors are ongoing; enrollment of eligible patients in prospective clinical trials is an essential way to improve patient outcomes.
Keywords:AI  aromatase inhibitor  ASCO  American Society of Clinical Oncology  CDK4/6  cyclin-dependent kinase 4/6  DCIS  ductal carcinoma in situ  DFS  disease-free survival  ER  estrogen receptor  FDA  Food and Drug Administration  HER2  human epidermal growth factor receptor 2  HR  hormone receptor  OS  overall survival  PFS  progression-free survival  PR  progesterone receptor  TNBC  triple negative breast cancer
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号